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Abstract
Background: Hepatic resection is the only effective treatment for combined hepatocellular carcinoma and
cholangiocarcinoma.
Case presentation: A 52-year-old man was preoperatively diagnosed with hepatocellular carcinoma in segment 2
with tumor thrombus in the segment 2 portal branch. Anatomical liver segmentectomy 2, including separation of
the hepatic arteries, portal veins, and bile duct, enabled us to remove the tumor and portal thrombus completely.
Modified selective hepatic vascular exclusion, which combines extrahepatic control of the left and middle hepatic
veins with occlusion of left hemihepatic inflow, was used to reduce blood loss. A pathological examination
revealed combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in the segment 2
portal branch. No postoperative liver failure occurred, and remnant liver function was adequate.
Conclusion: The separation method of the hepatic arteries, portal veins, and bile duct is safe and feasible for a
liver cancer patient with portal vein tumor thrombus. Modified selective hepatic vascular exclusion was useful to
control bleeding during liver transection. Anatomical liver segmentectomy 2 using these procedures should be
considered for a patient with a liver tumor located at segment 2 arising from a damaged liver.
Keywords: anatomical segmentectomy 2, portal vein tumor thrombus, combined hepatocellular carcinoma and
cholangiocarcinoma, modified selective hepatic vascular exclusion
Background
Combined hepatocellular carcinoma and cholangiocarci-
noma (cHCC-CC) is an uncommon primary liver cancer
subtype [1] and is difficult to correctly diagnose preo-
peratively. Most patients with cHCC-CC are preopera-
tively misdiagnosed with hepatocellular carcinoma
(HCC) or cholangiocarcinoma (CC) including our pre-
sent patient. Hepatic resection leads to improved survi-
val in patients with cHCC-CC [2-5] or HCC with portal
vein tumor thrombus (PVTT) [6,7]. In patients with
liver cirrhosis, extended liver resection for liver cancer is
sometimes not feasible because of decreased liver func-
tional reserve; therefore, anatomical segmentectomy or
limited non-anatomical hepatectomy must be per-
formed. We herein report an anatomical liver segmen-
tectomy 2 surgical procedure successfully performed for
a patient with cHCC-CC and PVTT in the segment 2
portal branch (P2) root arising from liver cirrhosis due
to hepatitis B virus. The Brisbane 2000 terminology of
liver anatomy and resections was used.
Patient and Method
A 52-year-old man was admitted to our hospital for
treatment of liver tumor. Five years previously, he under-
went splenectomy for hypersplenism due to liver cirrho-
sis, partial gastrectomy for early gastric cancer, and
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computed tomography (CT) revealed a high- and low-
density lesion in the arterial and venous phases, respec-
tively (Figure 1a and 1b). Although this tumor was fed
slightly by the left hepatic artery of segment 3, the tumor
location was liver segment 2 only. The lesion was 4 cm in
diameter and apposed the left hepatic vein. CT also
revealed PVTT in the root of P2 (Figure 1c), excluding
the umbilical and transverse portion of the left portal
vein (Figure 1d and 1e). Based on the CT volumetric
study excluding the volume of the tumor, the volumes of
total liver, left hemiliver, left lateral section, and segment
2 were 780, 351 (45% of the total liver), 320 (41%), and
164 cm
3 (21%), respectively. The Child-Pugh classifica-
tion status and the degree of liver damage scoring system
designed by the Liver Cancer Study Group of Japan [8]
were determined as class A (5 points) and class A,
respectively, based on laboratory data obtained at hospi-
talization (total bilirubin: 1.2 mg/dL, albumin: 4.5 g/dL,
prothrombin activity: 98.4%, aspartate aminotransferase:
31 IU/L, alanine aminotransferase: 27 IU/L, and indocya-
nine green retention value at 15 min after intravenous
injection (ICG-R15): 24%). Considering the impaired
liver function indicated by an ICG-R15 of 24% and the
hypertrophied left lateral section, we decided to perform
anatomical liver segmentectomy 2 rather than left hepa-
tectomy or left lateral sectionectomy.
Surgical technique
An upper median skin incision was made, and the
round ligament was ligated and divided. We routinely
conduct intraoperative ultrasonography for hepatectomy
to define the tumor location and vessels to be manipu-
lated for resection. The left lateral section was mobilized
by incising the falciform, left coronary, and left triangu-
lar ligaments. The left lateral section was retracted to
the right, and the Arantius canal was transected on both
sides of the umbilical portion of the left portal vein and
left hepatic vein. Arantius canal transaction on the side
of the left hepatic vein with retraction of the mobilized
left lateral section made it easier to encircle the extrahe-
patic portion of the common trunk of the middle and
left hepatic veins. The common bile duct, left portal
vein, and left hepatic artery feeding segments 2 and 3
were encircled in the hepatic hilum separately. The
round ligament was retracted anteriorly, and the umbili-
cal portion of the left portal vein was exposed by dis-
secting the serosa of the umbilical fissure. The left
hepatic arteries of segment 2 (A2) and 3 (A3) were
encircled at the left side of the umbilical portion of the
left portal vein after thorough mobilization, and encir-
cling of the umbilical and transverse portions of the left
portal vein and P2 by sacrificing one of the portal
branches supplying segment 1 (Figure 2a). After A2 was
ligated and divided, the liver parenchyma was dissected
a  b  c 
d  e 
Figure 1 Dynamic computed tomography revealed a tumor in segment 2 of the liver, which was high and low density in the arterial
(a) and venous phases (b), respectively, and portal vein tumor thrombus in the portal branch root of segment 2 (arrow) (c). Portal vein
tumor thrombus did not invade to umbilical and transverse portions (UP and TP) of the left portal vein (d, e). P3, portal branch of segment 3;
LHV, left hepatic vein.
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(CUSA
®) under left hemihepatic vascular occlusion [9]
f r o mt h ep e r i p h e r yt o w a r dt h ev e n ac a v aa l o n gt h e
demarcation line separating segments 2 and 3 that
appeared by clamping the umbilical portion of the left
portal vein and A3. Bleeding from the left hepatic vein
during transection was controlled using an extrahepatic
clamp on the common trunk of the middle and left
a 
b 
Figure 2 Left hepatic arteries of segment 2 (A2) and 3 (A3), umbilical and transverse portions (UP and TP) of the left portal vein, and
portal branch of segment 2 (P2) were encircled (a). Segment 2 and remnant liver were connected only through the portal branch and bile
duct of segment 2 (P2 and B2) (b). LHA, left hepatic artery. LHV, left hepatic vein.
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remnant liver were connected through only P2 and the
segment 2 bile duct (B2) (Figure 2b). Following ligation
and division of the B2, P2 was incised at its origin after
clamping the umbilical and transverse portions of the
left portal vein to ensure complete removal of the
tumor thrombus under direct vision. The P2 stump was
then closed with continuous sutures. The cut surface of
the liver with exposure of the left hepatic vein, indicat-
ing the anatomical landmark dividing segments 2 and 3.
Operative and left hemihepatic vascular occlusion times
were 419 and 92 min, and blood loss during the operation
and liver dissection were 939 and 500 ml. No blood trans-
fusions were required during or after operation.
The postoperative course was good, with peak levels
of serum aspartate aminotransferase, alanine amino-
transferase, and total bilirubin of 264 IU/L, 243 IU/L,
and 1.6 mg/dl. A left portal vein thrombus was revealed
by CT and ultrasonography on postoperative day 8;
however, this thrombus disappeared with anti-coagulant
therapy. He was discharged 17 days after surgery.
Macroscopically, PVTT was found in P2, and the sur-
gical margin of PVTT was 1 mm (Figure 3a). Microsco-
pically, the tumor was composed of HCC with
trabecular structure and adenocarcinoma (Figure 3b),
suggesting cHCC-CC. The patient is alive 9 months
after surgery, and has been undergoing systemic che-
motherapy using orally administered S-1 for multiple
lymph nodes metastasis.
Discussion
The World Health Organization [10] defined cHCC-CC
as a rare tumor containing unequivocal elements of inti-
mately admixed HCC and CC. This tumor is distin-
guished from separate HCC and CC arising within the
same liver. Patients with cHCC-CC and HCC are clini-
copathologically similar in average age at the time of
diagnosis (i.e., 50-60 years old), with a male predomi-
nance, viral hepatitis, elevated a-fetoprotein, and liver
cirrhosis [3,4,11], and clinicopathological features in our
case were similar to the above data. It is difficult to
make a differential diagnosis of cHCC-CC or HCC;
however, therapeutic options for patients with these
tumors are almost the same, and liver resection leads to
improved survival for both tumors [2-7].
Because a liver tumor located in segment 2 with PVTT
in P2 is thought to readily metastasize through the portal
venous flow to segments 3 and 4, left hepatectomy is the
first choice of treatment. Left lateral sectionectomy is the
second choice because the tumor was close to the left
hepatic vein. However, in patients with liver cirrhosis, the
left lateral section hypertrophies, and left hepatectomy or
left lateral sectionectomy are sometimes not feasible
because of decreased liver functional reserve and the
relatively large volume of the left hemiliver or left lateral
section [12]. In our case, the left hemiliver and left lateral
section became large (45% and 41% of the total liver,
respectively) and the ICG-R15 level was relatively high
(24%). And we judged preoperatively that we can exfoli-
ate the tumor from the left hepatic vein. Therefore, ana-
tomical liver segmentectomy 2 rather than left
hepatectomy or left lateral sectionectomy was selected
because it optimizes the balance between oncological
requirements and the need to spare functioning liver par-
enchyma. Although preoperative surgical planning was
evaluated by two-dimensional CT in our case, we think
that three-dimensional CT computer-assisted preopera-
tive surgical planning may be helpful for anatomical liver
segmentectomy 2 [13]. In anatomical segmentectomy 2,
transection of the glissonean pedicle that feeds segment 2
[12] and intraoperative ultrasound-guided blunt com-
pression of the segment 2 portal branch [14] have been
reported; however, these techniques are not suitable in
liver cancer patients with PVTT in the root of P2, includ-
ing our patient. In such cases, complete removal of
PVTT is extremely important to prevent early tumor
recurrence; therefore, after A2, A3, P2, and umbilical and
transverse portions of the left portal vein were separated,
the liver was dissected, and PVTT was removed under
direct vision. It is easy to ligate and divide the origin of
P2 before liver transection; however, we think that it is
safer and more certain to incise the origin of P2 and
suture the stump of P2 after liver transection than before
liver transection. This separation method could be
adapted for segmentectomy 3 and segmentectomy 3 and
4 [15]. Although several reports [16,17] have demon-
strated the feasibility and safety of laparoscopic anatomic
resection based on three-dimensional CT images
recently, we performed anatomical liver segmentectomy
2 by open surgery because laparoscopic approach to
hepatic tumors remains a challenge, and the patient in
present report underwent upper abdominal surgeries
(splenectomy, partial gastrectomy, and cholecystectomy).
Left hemihepatic vascular occlusion, limited to 30 min
followed by 5 min of perfusion, is useful to prevent blood
loss originating from hepatic inflow [9]; however, it is dif-
ficult to control retrograde bleeding from the left hepatic
vein using this maneuver. Selective hepatic vascular
exclusion (SHVE), which combines inflow vascular occlu-
sion (Pringle maneuver) with extrahepatic control of the
major hepatic veins, overcomes the drawbacks of back-
flow bleeding of the Pringle maneuver [18]. In segmen-
tectomy 2 or 3, modified selective hepatic vascular
exclusion (m-SHVE), which combines extrahepatic con-
trol of the middle and left hepatic veins with left hemihe-
patic inflow occlusion, is sufficient to reduce both
backflow and inflow bleeding. In our case, this m-SHVE
procedure contributed to reduce bleeding during liver
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changes. SHVE has been used in major liver resections to
control intraoperative bleeding [19,20]; however, this
technique has not been reported and studied in
anatomical liver segmentectomy 2, to our knowledge.
Furthermore, although it is reported in previous publica-
tions that SHVE entails Pringle maneuver and extrahe-
paic clamping of major hepatic veins [19,20], m-SHVE
a 
b 
Figure 3 Portal vein tumor thrombus (PVTT) in the segment 2 portal branch (P2) (a). Microscopically, the tumor was combined
hepatocellular carcinoma and cholangiocarcinoma (Hematoxylin and eosin staining; magnification ×10) (b).
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inflow occlusion has not been reported. Therefore, anato-
mical liver segmentectomy 2 with m-SHVE is the novel
technique. We think that this m-SHVE is the effective
technique in anatomical liver segmentectomy 2 and can
be adapted also for anatomical liver segmentectomy 3.
Intraabdominal adhesion resulting from previous surgery
was very severe, and then, about 120 min were required
and blood loss was about 400 ml during exfoliation of
this adhesion. Therefore, we think that the operative time
(419 min) and the amount of blood loss (939 ml) in our
case seem in the tolerance. The liver transection time
was relatively longer because of the hard texture of liver
parenchyma resulting from liver cirrhosis. Because post-
operative liver function was adequate in our case, anato-
mical segmentectomy 2 is feasible to preserve remnant
liver function in selected patients with liver cirrhosis.
Survival of patients with cHCC-CC was significantly
poorer than that of HCC or CC patients [3-5], and the
PVTT was found to be significant predictor of poor
outcome [3,5]. In our case, the patient is alive 9
months after surgery with lymph nodes metastasis.
Although limited hepatectomy was performed, the
patient has no recurrence in the remnant liver. There-
fore, in selected patients with liver cirrhosis, limited
hepetectomy including anatomical segmentectomy 2
may be an appropriate operation even if patients have
the PVTT.
Conclusions
The hepatic arteries, portal veins, and bile duct separa-
tion method is a useful approach for a liver cancer
patient with PVTT, and m-SHVE is effective for mini-
mizing bleeding during liver resection of segmentectomy
2. Anatomical liver segmentectomy 2 contributes to pre-
serve remnant liver function; however, further investiga-
tion is needed to evaluate the overall survival rates in
patients who undergo segmentectomy 2.
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